Position in AUPH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,161,060
+$1,501,267 QoQ
Shares Held
363,056
+15.5% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#34
of 279 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $36,393,027 across 25 Biotechnology names. AUPH ranks #1 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
This page
|
363,056 | $6,161,060 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
749,798 | $6,080,861 | |
| 3 | EXEL |
Exelixis, Inc.
|
68,589 | $3,731,927 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
94,450 | $3,694,884 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
13,306 | $3,206,346 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,709 | $2,339,101 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
25,095 | $2,046,999 | |
| 8 | INVA |
Innoviva, Inc.
|
52,793 | $1,198,929 |
All Filings in AUPH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,161,060 | 363,056 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,659,793 | 314,426 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,128,115 | 258,816 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $933,890 | 84,515 | Shares | Sole | 2025-10-28 | |
| No filing history on record for this holder in this stock. | ||||||